Aurobindo Pharma acquires Khandelwal Labs’ non-oncology business for Rs 325 crore
Published on: Jan. 2, 2026, 10:56 a.m. | Source: The Financial Express
Aurobindo Pharma’s wholly owned subsidiary Auro Pharma acquires Khandelwal Laboratories’ non-oncology prescription formulations business for Rs 325 crore in a cash slump sale
